已收盘 02-06 16:00:00 美东时间
+0.690
+3.01%
今日重点评级关注:Ascendiant Capital:维持GRI Bio"买入"评级,目标价从35美元升至36美元;Ascendiant Capital:维持Atossa Therapeutics"买入"评级,目标价从7.75美元升至8美元
2025-12-09 10:32
Barclays analyst Matthew Bouley initiates coverage on James Hardie Industries (NYSE:JHX) with a Equal-Weight rating and announces Price Target of $21.
2025-12-08 20:18
JHX Investors with Losses Encouraged to Contact Firm SAN FRANCISCO, Dec. 3, 2025 /PRNewswire/ -- National shareholder rights law firm Hagens Berman reminds investors that the deadline to mov...
2025-12-04 04:05
今日重点评级关注:富国银行:维持Annexon"超配"评级,目标价从14美元升至27美元;瑞穗:上调Relmada Therapeutics评级至"跑赢大市",目标价从1美元升至10美元
2025-11-20 10:28
Forms Integration and Performance Committee of the BoardJames Hardie Industries plc (NYSE/ASX: JHX) ("James Hardie" or the "Company"), a leading provider of exterior home and outdoor living solutions, today announced the
2025-11-18 05:43
Citigroup analyst Samuel Seow upgrades James Hardie Industries (NYSE:JHX) from Neutral to Buy.
2025-11-04 20:10
华尔街最受关注、且能影响市场走势的研究评级报告现已汇总于此。以下是由 The Fly 整理的今日投资者需重点关注的评级信息。 五大评级上调案例 思佳讯...
2025-10-29 22:12
SAN FRANCISCO, Oct. 27, 2025 /PRNewswire/ -- A class-action lawsuit has been filed against James Hardie Industries plc (NYSE: JHX), the dominant producer of fiber cement building materials i...
2025-10-28 05:58